These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 11531834

  • 1. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial.
    Reitamo S, Spuls P, Sassolas B, Lahfa M, Claudy A, Griffiths CE, Sirolimus European Psoriasis Study Group.
    Br J Dermatol; 2001 Sep; 145(3):438-45. PubMed ID: 11531834
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile.
    Meffert H, Bräutigam M, Färber L, Weidinger G.
    Acta Derm Venereol; 1997 Mar; 77(2):137-41. PubMed ID: 9111826
    [Abstract] [Full Text] [Related]

  • 4. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
    Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A.
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R, Sánchez Regaña M, Massana J, Oliete R, Umbert P.
    J Dermatolog Treat; 2005 Jul; 16(4):238-41. PubMed ID: 16249146
    [Abstract] [Full Text] [Related]

  • 6. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).
    Salek MS, Finlay AY, Lewis JJ, Sumner MI.
    Qual Life Res; 2004 Feb; 13(1):91-5. PubMed ID: 15058791
    [Abstract] [Full Text] [Related]

  • 7. Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial.
    Ormerod AD, Shah SA, Copeland P, Omar G, Winfield A.
    Br J Dermatol; 2005 Apr; 152(4):758-64. PubMed ID: 15840110
    [Abstract] [Full Text] [Related]

  • 8. Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
    Gottlieb AB, Griffiths CE, Ho VC, Lahfa M, Mrowietz U, Murrell DF, Ortonne JP, Todd G, Cherill R, Marks I, Emady-Azar S, Paul CF, Multi-Centre Investigator Group.
    Br J Dermatol; 2005 Jun; 152(6):1219-27. PubMed ID: 15948985
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis.
    Shintani Y, Kaneko N, Furuhashi T, Saito C, Morita A.
    J Dermatol; 2011 Oct; 38(10):966-72. PubMed ID: 21545506
    [Abstract] [Full Text] [Related]

  • 10. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
    Zachariae H, Abrams B, Bleehen SS, Bräutigam M, Burrows D, Ettelt MJ, Fry L, Happle R, Haustein UF, Ganslandt J, Jung EG, Knop J, Kühne KH, Mellein B, Mørk NJ, Rogers S, Schmidt AG, Schopf RE, Sumner M, Taube KM, Weidinger G, Wurdel C, Zahn E.
    Dermatology; 1998 Oct; 196(2):231-6. PubMed ID: 9568413
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C, Grossman R, Abi-Rached J, Abeywickrama KH, Dubertret L.
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study.
    Vena GA, Galluccio A, Pezza M, Vestita M, Cassano N.
    J Dermatolog Treat; 2012 Aug; 23(4):255-60. PubMed ID: 21756153
    [Abstract] [Full Text] [Related]

  • 13. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007 Aug; 8(2):103-12. PubMed ID: 17324008
    [Abstract] [Full Text] [Related]

  • 14. Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy.
    Ito T, Furukawa F, Iwatsuki K, Matsue H, Shimada S, Takigawa M, Tokura Y.
    J Dermatol; 2014 May; 41(5):377-81. PubMed ID: 24628433
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporin in childhood psoriasis.
    Perrett CM, Ilchyshyn A, Berth-Jones J.
    J Dermatolog Treat; 2003 Jun; 14(2):113-8. PubMed ID: 12775319
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I, Nakayama J, Murakami H, Hori Y, Higuchi S.
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [Abstract] [Full Text] [Related]

  • 17. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.
    Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, Kobza Black A, Greaves MW.
    Br J Dermatol; 2000 Aug; 143(2):365-72. PubMed ID: 10951147
    [Abstract] [Full Text] [Related]

  • 18. Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT).
    Lebwohl M, Blauvelt A, Paul C, Sofen H, Węgłowska J, Piguet V, Burge D, Rolleri R, Drew J, Peterson L, Augustin M.
    J Am Acad Dermatol; 2018 Aug; 79(2):266-276.e5. PubMed ID: 29660425
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.
    Tournier A, Khemis A, Maccari F, Reguiai Z, Bégon E, Fougerousse AC, Amy de la Breteque M, Beneton N, Parier J, Boyé T, Avenel-Audran M, Girard C, Pallure V, Perrot JL, Bastien M, Mahé E, Beauchet A, GEM Resopso.
    Ann Dermatol Venereol; 2019 Feb; 146(2):106-114. PubMed ID: 30704943
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group.
    Koo J.
    Br J Dermatol; 1998 Jul; 139(1):88-95. PubMed ID: 9764154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.